Trisalus Life Sciences, Inc. · NASDAQ:TLSI

Marshak Richard sold 325 Trisalus Life Sciences, Inc. shares (Form 4)

Traded Oct 5, 2026 · Filed Oct 7, 2026

On Oct 5, 2026, Marshak Richard (Chief Commercial Officer) sold 325 Trisalus Life Sciences, Inc. shares at US$4.39 for US$1,427, leaving 127,994 shares. Filed Oct 7, 2026 (Form 4).

Sold
325 shares
Price
US$4.39
Value
US$1,427
Holding after
127,994 shares
Trading plan
No
Role
Chief Commercial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 5, 2026Common StockSale325US$4.39127,994Direct

Source

View original at SEC

Related